4//SEC Filing
ARGOS THERAPEUTICS INC 4
Accession 0000899243-16-016128
CIK 0001105533operating
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 4:36 PM ET
Size
8.1 KB
Accession
0000899243-16-016128
Insider Transaction Report
Form 4
Birner Hubert
Director10% Owner
Transactions
- Purchase
Common Stock
2016-03-14+183,697→ 1,654,788 total(indirect: See Footnote) - Purchase
Common Stock Warrants (right to buy)
2016-03-14+137,773→ 137,773 total(indirect: See Footnote)Exercise: $5.35From: 2016-03-14Exp: 2021-03-14→ Common Stock (137,773 underlying)
Footnotes (2)
- [F1]The reported securities are included within Units purchased by the Reporting Person for $5.44375 per Unit. Each Unit consists of one share of common stock and one warrant to purchase 0.75 shares of common stock.
- [F2]The reported securities are directly held by TVM V Life Science Ventures GmbH & Co. KG ("TVM V"), the managing limited partner of which is TVM V Life Science Ventures Management GmbH & Co. KG ("TVM V Management"), for which the Reporting Person, Stefan Fischer ("Fischer"), Alexandra Goll ("Goll") and Axel Polack ("Polack"), each a member of the investment committee of TVM V Management, share voting and investment authority over the securities held by TVM V. Each of TVM V Management, the Reporting Person, Fischer, Goll and Polack disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, if any.
Documents
Issuer
ARGOS THERAPEUTICS INC
CIK 0001105533
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001105533
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 4:36 PM ET
- Size
- 8.1 KB